At one injection per week, these risks are minimal
[23] By comparison, the placebo condition caused no changes except a 13% increase in triglycerides
Adverse effects These drugs are not being regulated as tightly, which could lead to inconsistent dosages , unverified ingredients, or contaminants, increasing the risk of severe nausea, vomiting, diarrhea, blood sugar fluctuations, allergic reactions, and infections
Each vial contains a combination of high-purity Retatrutide formulated under stringent quality control standards to ensure stability, precision, and consistency in controlled experimental research
It could also become an ethical issue
Currently, there are three FDA-approved oral GLP-1s on the market in the US: Rybelsus, which is approved for type 2 diabetes, the Wegovy pill, which is approved for weight loss, and Foundayo, which is also approved for weight loss